3rd Quarter - Report
W STRATEGIES, LLC for BIOGEN
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. H.R. 1281: Newborn Screening Saves Lives Reauthorization Act of 2013. H.R. 3303: SOFTWARE Act of 2013. Education about the value of innovative new medicines.Legislative efforts to help accelerate the discovery, development and delivery of promising new treatments to patients (21st Century Cures).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.